Published in Clin Chem on August 01, 2005
Neutrophil Extracellular Traps and Thrombolysis in the Acute Stroke (NETs) | NCT02476188
Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin. Cell (2016) 2.03
Prognostic utility and characterization of cell-free DNA in patients with severe sepsis. Crit Care (2012) 1.18
The origin and properties of extracellular DNA: from PAMP to DAMP. Clin Immunol (2012) 1.08
The uptake of apoptotic cells drives Coxiella burnetii replication and macrophage polarization: a model for Q fever endocarditis. PLoS Pathog (2008) 1.06
Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc Natl Acad Sci U S A (2016) 1.06
Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology. J Mol Diagn (2015) 1.04
Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer. Clin Cancer Res (2013) 1.02
DNA methylation as clinically useful biomarkers-light at the end of the tunnel. Pharmaceuticals (Basel) (2012) 0.99
Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients. Oncol Lett (2012) 0.98
Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity. Cell (2016) 0.93
Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology. Onco Targets Ther (2013) 0.92
Elevated levels of cell-free circulating DNA in patients with acute dengue virus infection. PLoS One (2011) 0.92
Elevated levels of circulating DNA in cardiovascular disease patients: metagenomic profiling of microbiome in the circulation. PLoS One (2014) 0.91
Complete genes may pass from food to human blood. PLoS One (2013) 0.87
High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA. BMC Med Genomics (2015) 0.87
Nucleosomes as a new prognostic marker in early cerebral stroke. J Neurol (2007) 0.87
The struggle to detect circulating DNA. Crit Care (2006) 0.85
Increased levels of circulating IL-16 and apoptosis markers are related to the activity of Whipple's disease. PLoS One (2007) 0.82
Fragment size analysis of free fetal DNA in maternal plasma using Y-STR loci and SRY gene amplification. Nagoya J Med Sci (2011) 0.81
Evaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinoma. Clin Chem Lab Med (2014) 0.79
Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas. BMC Cancer (2012) 0.79
Methyl-binding domain protein-based DNA isolation from human blood serum combines DNA analyses and serum-autoantibody testing. BMC Clin Pathol (2011) 0.79
Long-term persistence and effects of fetal microchimerisms on disease onset and status in a cohort of women with rheumatoid arthritis and systemic lupus erythematosus. BMC Musculoskelet Disord (2013) 0.78
Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments. BMC Cancer (2006) 0.76
Effect of deoxyribonuclease I treatment for dementia in end-stage Alzheimer's disease: a case report. J Med Case Rep (2016) 0.75
Advances in the medical research and clinical applications on the plasma DNA. Transl Pediatr (2014) 0.75
Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation. Cell Death Dis (2016) 0.75
Development and Evaluation of a Duplex Real-Time PCR Assay With a Novel Internal Standard for Precise Quantification of Plasma DNA. Ann Lab Med (2017) 0.75
Detection and characterization of placental microRNAs in maternal plasma. Clin Chem (2008) 6.40
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A (2008) 5.94
Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ (2011) 4.50
Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91
Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem (2002) 3.72
Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients. Clin Cancer Res (2009) 3.41
Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients. Clin Cancer Res (2004) 2.81
Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem (2004) 2.79
Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem (2008) 2.78
Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem (2002) 2.74
Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults. Gastroenterology (2013) 2.71
Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst (2002) 2.61
Circulating nucleic acids in plasma/serum. Pathology (2007) 2.53
Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations. Clin Chem (2006) 2.41
Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One (2011) 2.29
Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin Chem (2008) 2.14
Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Clin Cancer Res (2006) 2.13
Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases. J Pathol (2004) 2.09
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing. Proc Natl Acad Sci U S A (2013) 2.05
Early diagnosis of SARS coronavirus infection by real time RT-PCR. J Clin Virol (2003) 2.05
Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma. J Clin Oncol (2006) 1.92
mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci U S A (2003) 1.89
Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem (2006) 1.85
Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A (2005) 1.81
Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem (2009) 1.80
Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin Chem (2009) 1.76
Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA. Clin Chem (2013) 1.72
Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem (2002) 1.72
Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome. Clin Chem (2003) 1.67
Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci U S A (2008) 1.64
Nonhematopoietically derived DNA is shorter than hematopoietically derived DNA in plasma: a transplantation model. Clin Chem (2011) 1.63
Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol (2007) 1.63
Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem (2002) 1.59
Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer. Oncology (2006) 1.58
Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Clin Cancer Res (2002) 1.57
Paneth cells in intestinal homeostasis and tissue injury. PLoS One (2012) 1.57
Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem (2003) 1.53
IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo. Ann Neurol (2011) 1.53
Presence of donor-derived DNA and cells in the urine of sex-mismatched hematopoietic stem cell transplant recipients: implication for the transrenal hypothesis. Clin Chem (2008) 1.45
Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: pretreatment levels or kinetics during chemotherapy? Onkologie (2007) 1.42
Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles. Clin Chem (2010) 1.42
Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood (2002) 1.42
Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet (2002) 1.41
Clinical use of circulating nucleosomes. Crit Rev Clin Lab Sci (2009) 1.41
Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res (2003) 1.39
Quantitative analysis of circulating mitochondrial DNA in plasma. Clin Chem (2003) 1.38
Soluble MICA in malignant diseases. Int J Cancer (2006) 1.36
Tumor markers in breast cancer- European Group on Tumor Markers recommendations. Tumour Biol (2005) 1.36
Time course of early and late changes in plasma DNA in trauma patients. Clin Chem (2003) 1.35
Diagnostic developments involving cell-free (circulating) nucleic acids. Clin Chim Acta (2005) 1.34
Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem (2002) 1.33
Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events. Nat Clin Pract Cardiovasc Med (2009) 1.31
Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to β-thalassemia. Clin Chem (2012) 1.30
Coronavirus genomic-sequence variations and the epidemiology of the severe acute respiratory syndrome. N Engl J Med (2003) 1.29
Non-invasive prenatal diagnosis by single molecule counting technologies. Trends Genet (2009) 1.27
Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort. PLoS One (2012) 1.25
Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals. Scand J Gastroenterol (2010) 1.24
Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood (2011) 1.23
Clinical relevance of circulating nucleosomes in cancer. Ann N Y Acad Sci (2008) 1.23
Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer. Clin Cancer Res (2008) 1.22
Progressive cerebellar atrophy and polyneuropathy: expanding the spectrum of PNKP mutations. Neurogenetics (2012) 1.21
OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer. Clin Cancer Res (2008) 1.20
Cell-free nucleic acids in plasma, serum and urine: a new tool in molecular diagnosis. Ann Clin Biochem (2003) 1.19
Plasma nucleic acids in the diagnosis and management of malignant disease. Clin Chem (2002) 1.19
Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. J Clin Virol (2004) 1.18
Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. Clin Chem (2009) 1.18
Nucleosomal DNA fragments in autoimmune diseases. Ann N Y Acad Sci (2006) 1.16
Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma. Clin Cancer Res (2003) 1.16
Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer. Am J Gastroenterol (2011) 1.16
Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.15
Simvastatin initiated early after heart transplantation: 8-year prospective experience. Circulation (2003) 1.14
Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma. Clin Chem (2008) 1.13
MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. Proc Natl Acad Sci U S A (2004) 1.12
Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA. Cancer Immunol Immunother (2006) 1.11
Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma. Semin Cancer Biol (2002) 1.11
Quantification of plasma beta-catenin mRNA in colorectal cancer and adenoma patients. Clin Cancer Res (2004) 1.10
Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J Clin Endocrinol Metab (2014) 1.09
Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age. Semin Fetal Neonatal Med (2010) 1.08